Chesapeake Wealth Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-917
| Closed | -$230K | – | 165 |
|
|
2025
Q4 | $230K | Hold |
917
| – | – | 0.07% | 146 |
|
|
2025
Q3 | $263K | Sell |
917
-18
| -2% | -$4.82K | 0.08% | 145 |
|
|
2025
Q2 | $245K | Hold |
935
| – | – | 0.08% | 147 |
|
|
2025
Q1 | $218K | Sell |
935
-185
| -17% | -$44.9K | 0.08% | 150 |
|
|
2024
Q4 | $257K | Sell |
1,120
-25
| -2% | -$5.74K | 0.09% | 147 |
|
|
2024
Q3 | $256K | Hold |
1,145
| – | – | 0.09% | 143 |
|
|
2024
Q2 | $233K | Sell |
1,145
-152
| -12% | -$30.9K | 0.08% | 147 |
|
|
2024
Q1 | $283K | Hold |
1,297
| – | – | 0.1% | 128 |
|
|
2023
Q4 | $295K | Hold |
1,297
| – | – | 0.11% | 129 |
|
|
2023
Q3 | $261K | Sell |
1,297
-280
| -18% | -$59.1K | 0.11% | 133 |
|
|
2023
Q2 | $327K | Hold |
1,577
| – | – | 0.13% | 122 |
|
|
2023
Q1 | $311K | Sell |
1,577
-135
| -8% | -$27.8K | 0.13% | 124 |
|
|
2022
Q4 | $346K | Sell |
1,712
-98
| -5% | -$19.2K | 0.15% | 125 |
|
|
2022
Q3 | $318K | Sell |
1,810
-12
| -0.7% | -$2.46K | 0.15% | 127 |
|
|
2022
Q2 | $366K | Hold |
1,822
| – | – | 0.16% | 126 |
|
|
2022
Q1 | $412K | Sell |
1,822
-11
| -0.6% | -$2.59K | 0.15% | 131 |
|
|
2021
Q4 | $494K | Hold |
1,833
| – | – | 0.17% | 123 |
|
|
2021
Q3 | $443K | Sell |
1,833
-184
| -9% | -$46.4K | 0.16% | 134 |
|
|
2021
Q2 | $478K | Sell |
2,017
-70
| -3% | -$15.9K | 0.16% | 141 |
|
|
2021
Q1 | $458K | Sell |
2,087
-14
| -0.7% | -$2.81K | 0.15% | 136 |
|
|
2020
Q4 | $367K | Hold |
2,101
| – | – | 0.13% | 159 |
|
|
2020
Q3 | $340K | Sell |
2,101
-44
| -2% | -$6.97K | 0.13% | 153 |
|
|
2020
Q2 | $307K | Hold |
2,145
| – | – | 0.12% | 157 |
|
|
2020
Q1 | $233K | Hold |
2,145
| – | – | 0.11% | 163 |
|
|
2019
Q4 | $312K | Sell |
2,145
-88
| -4% | -$12.7K | 0.12% | 161 |
|
|
2019
Q3 | $322K | Sell |
2,233
-58
| -3% | -$8.46K | 0.13% | 149 |
|
|
2019
Q2 | $340K | Sell |
2,291
-302
| -12% | -$42.1K | 0.14% | 147 |
|
|
2019
Q1 | $341K | Sell |
2,593
-181
| -7% | -$22.3K | 0.15% | 147 |
|
|
2018
Q4 | $301K | Sell |
2,774
-256
| -8% | -$34.3K | 0.15% | 143 |
|
|
2018
Q3 | $452K | Hold |
3,030
| – | – | 0.2% | 118 |
|
|
2018
Q2 | $467K | Sell |
3,030
-229
| -7% | -$34.6K | 0.22% | 112 |
|
|
2018
Q1 | $453K | Buy |
+3,259
| New | +$479K | 0.21% | 110 |
|
Other funds holding LH
VCM
VPM
Chesapeake Wealth Management's LH Position: Q1 2026 in Review
Chesapeake Wealth Management sold out of Labcorp (LH) in Q1 2026, closing a stake of 917 shares — an estimated $230K sold.
Chesapeake Wealth Management first reported a position in LH in Q1 2018 and held it in 32 quarters. The position peaked at $494K in Q4 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Chesapeake Wealth Management reported no remaining Labcorp position as of Q1 2026 after selling out during the quarter.
- Chesapeake Wealth Management sold 917 Labcorp shares in Q1 2026, an estimated $230K.
- Chesapeake Wealth Management first reported a position in Labcorp in Q1 2018 and held it in 32 quarters.
- Chesapeake Wealth Management's Labcorp position peaked at $494K in Q4 2021.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Chesapeake Wealth Management's 13F filing for Q1 2026, filed 18 May 2026.